microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer

microRNA-217 (miR-217) is frequently dysregulated in cancer. Here, we report that miR-217 levels were lower in tumor tissue compared with the adjacent normal tissue. Low levels of miR-217 were associated with aggressive tumor phenotypes and poor overall survival in gastric cancer patients. The ectop...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Chen, Dong-liang, Zhang, Dong-sheng, Lu, Yun-xin, Chen, Le-zong, Zeng, Zhao-lei, He, Ming-ming, Wang, Feng-hua, Li, Yu-hong, Zhang, Hui-zhong, Pelicano, Helene, Zhang, Wei, Xu, Rui-hua
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4484425/
https://ncbi.nlm.nih.gov/pubmed/25869101
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares